Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0021390 (
inflammatory bowel disease
)
23,302
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
One hundred and twenty-eight of 145 patients with ankylosing spondylitis (AS) were found to be HLA
B27
positive. Five patients had evidence of a sero-negative peripheral arthritis resembling peripheral psoriatic arthritis and 3 of these were
B27
negative. One further
B27
negative patients had a sister with ankylosing spondylitis and ulcerative colitis and a mother with ulcerative colitis. There was evidence of a somewhat later age of onset of symptoms in
B27
negative patients. These findings are interpreted as suggesting some degree of clinical and genetic heterogeneity in ankylosing spondylitis with genes for psoriasis and
inflammatory bowel disease
being important in some individuals, particularly those who are
B27
negative. Twenty-five first-degree relatives with ankylosing spondylitis were all
B27
positive. The only instance of disassociation of
B27
and spondylitis in a family was where the proband had ulcerative colitis as well as spondylitis. Of 13
B27
positive fathers 3 could be diagnosed as having definite ankylosing spondylitis (23%). These findings are thought to provide evidence against the concept that the gene for ankylosing spondylitis is not
B27
but a closely linked gene and favour the occurrence of an environmental event affecting approximately one-fifth of
B27
positive males to result in disease.
...
PMID:HLA B27 and the genetics of ankylosing spondylitis. 10 68
The incidence of
B27
in patients with ankylosing spondylitis associated with regional enteritis was significantly lower than in ankylosing spondylitis without
inflammatory bowel disease
. It was significantly higher, however, than in a control group of blood donors. The incidence of
B27
was found to be nil in patients with regional entertitis without ankylosing spondylitis, as well as in patients with regional enteritis and asymptomatic radiographic sacroilitis. Conversely, all patients with regional enteritis, positive for
B27
, developed ankylosing spondylitis.
...
PMID:HLA B27 in regional enteritis with and without ankylosing spondylitis or sacroiliitis. 26
A family with 4 of 10 first-degree relatives affected with
inflammatory bowel disease
(
IBD
) was studied to determine whether any distinct immunological abnormalities occur in the affected members, as compared with unaffected members of the family, normal controls, and other unrelated patients with
IBD
. Red cell blood type and HL-A phenotypes did not distinguish between healthy and affected members, although HL-A2, 32,
B27
, and B12 were the predominant haplotypes in members with
IBD
. There was no significant difference between the two groups in the lymphocyte subpopulation counts of T cells, B cells, and cells carrying Fc or complement receptors. The in vitro mitogen response, however, to phytohemagglutinin and pokeweed mitogen were depressed in the affected members. Serum IgA and C3 levels were significantly elevated in members with
IBD
compared to healthy subjects with values of 232 +/- 69 (mean +/- SD) versus 148 +/- 29 mg per dl for IgA (P less than 0.05) and 173 +/- 32 versus 115 +/- 22 mg per dl for C3 (P less than 0.025), respectively. Plasma and, to a lesser extent, peripheral lymphocytes from 2 affected members who were tested were cytotoxic to allogeneic colonic epithelial cells. Salivary IgA was normal in the affected family members and unrelated patients with
IBD
. However, the free secretory component of salivary IgA was absent or markedly depressed in family members, as well as in unrelated patients with ulcerative colitis. This deficiency of the secretory immune system appears to characterize more frequently ulcerative colitis than Crohn's disease and may compromise mucosal host defenses in
IBD
.
...
PMID:Secretory immunoglobulin deficiency in a family with inflammatory bowel disease. 41 31
To establish the prevalence of peripheral arthritis, radiographic sacroiliitis, and ankylosing spondylitis in patients with
inflammatory bowel disease
, 58 consecutive patients suffering from ulcerative colitis (UC) and 51 with Crohn's disease (CD) underwent a detailed rheumatological examination. In addition, all patients were screened for the presence of the antigen HLA
B27
. Peripheral arthritis was found in 14 (8 UC, 6 CD) patients (12.8%); radiographic sacroiliitis was diagnosed in 11 (5 UC, 6 CD) (10.1%), of whom 10 were asymptomatic; and ankylosing spondylitis was diagnosed in 2 UC and 2 CD patients (3.7%). 18.9% of the UC and 3.9% of the CD patients were HLA
B27
positive. One of the 11 patients with radiographic sacroiliitis and 2 of the 4 with ankylosing spondylitis had the HLA
B27
antigen. Peripheral arthritis, radiographic sacroiliitis, and ankylosing spondylitis are apparently frequent manifestations in patients suffering from
inflammatory bowel disease
. Asymptomatic radiographic sacroiliitis in these patients appears to differ from idiopathic ankylosing spondylitis, both clinically and genetically. Evaluation of subjective rheumatological complaints, necessary for a confident diagnosis of ankylosing spondylitis, according to the New York criteria is difficult during a flare-up of the inflammatory bowel process, as was shown in 4 CD cases with marked limitation of lumbovertebral function and chest expansion, but no radiological abnormalities of the SI joints.
...
PMID:Ankylosing spondylitis and inflammatory bowel disease. II. Prevalence of peripheral arthritis, sacroiliitis, and ankylosing spondylitis in patients suffering from inflammatory bowel disease. 62 1
A study was made, in co-operation with several gastroenterology and rheumatology centres, of the clinical and genetic characteristics (HLA
B27
) of 50 patients suffering from both
inflammatory bowel disease
(38 Crohn's disease (CD), 12 ulcerated colitis (UC)) and ankylosing spondylitis (AS), the latter diagnosis being established according to the New York criteria. 20 CD (52.6%) and 8 UC (66.7%) patients were HLA
B27
positive. The presence of HLA
B27
was studied in relation to clinical parameters, such as first occurrence of symptoms of AS or
inflammatory bowel disease
(
IBD
), a history of peripheral arthritis, iridocyclitis, and a positive history of AS or
IBD
. Our patients were found to have heterogeneous clinical features: on one side of the spectrum a group of cases was distingiushed with the typical characteristics of idiopathic AS, often being HLA
B27
positive. On the other side a smaller group of HLA
B27
negative patients was observed, with severe intestinal inflammatory pathology, lacking most of the typical clinical features of idiopathic AS ('secondary' form of AS). Finally, between these two extremes a group of patients was found with less pronounced clinical or genetic characteristics. These different clinical and histocompatibility patterns suggest a mixed aetiopathogenesis of AS in
IBD
patients. Such a 'syndrome' of AS might harbour both idiopathic AS and forms of AS 'secondary' to the intestinal inflammatory pathology.
...
PMID:Ankylosing spondylitis and inflammatory bowel disease. III. Clinical characteristics and results of histocompatibility typing (HLA B27) in 50 patients with both ankylosing spondylitis and inflammatory bowel disease. 62 2
HLA
B27
has been tested systematically in 246 patients attending a rheumatology clinic for chronic inflammatory arthritis or spondylitis. Patients were allocated to nine groups: typical ankylosing spondylitis, ankylosing spondylitis with moderate involvement without peripheral arthritis, ankylosing spondylitis with moderate involvement and with peripheral arthritis, juvenile chronic arthritis, Reiter's syndrome, Yersinia arthritis, arthropathies of
inflammatory bowel disease
, psoriatic arthritis, seronegative and seropositive rheumatoid arthritis. Except for seropositive rheumatoid arthritis, a significant association with HLA
B27
antigen was found in all groups. In the seronegative rheumatoid arthritis group HLA
B27
was present in 40% of the cases in contrast to 5.6% of the seropositive rheumatoid arthritis cases. These data confirm that a wide range of the so called "seronegative arthropathies" are associated with HLA
B27
and suggest that sex and HLA
B27
antigen are important factors in the manifestation of rheumatic disease. Women had less severe spondylitic changes but more peripheral arthritis of the small joints. Ankylosing spondylitis in its various forms had a comparable sex distribution despite relatively mild disease in females. The mean age of onset in the HLA
B27
associated diseases was found to be significantly lower than in the seropositive rheumatoid arthritis group.
...
PMID:A systematic survey of the HLA B27 prevalence in inflammatory rheumatic diseases. 73 94
In 89 patients with
inflammatory bowel disease
, only one out of 11 patients with radiographic sacroiliitis was found to possess the HLA
B27
antigen, while three out of four patients with ankylosing spondylitis were
B27
positive. This suggests that sacroiliitis in
inflammatory bowel disease
may not always be a precursor of ankylosing spondylitis.
...
PMID:Lack of association of HLA B27 with radiographic sacroiliitis in inflammatory bowel disease. 95 Jun 36
Lymphocyte typing for HL-A
B27
is useful under conditions in which data based on history and examination are suggestive but not diagnostic of a seronegative spondyloarthropathy. The presence of HL-A
B27
would increase the probability of a patient's having one of these entities, but its absence does not rule out such a diagnosis. Furthermore, tissue-typing allows one to predict the probability that a patient with
inflammatory bowel disease
will develop AS and the likelihood that the family member of a patient with AS will develop a related disease.
...
PMID:HL-A antigens and sacroiliitis. 98 87
Histocompatibility (HLA) antigen phenotypes have been studied in 100 patients with ulcerative colitis, 100 with Crohn's disease, and 283 normal controls. In addition the incidence of ankylosing spondylitis, sacroiliitis, and "enteropathic" peripheral arthropathy was determined in the patients with
inflammatory bowel disease
(
IBD
). There was no significant difference in antigen frequency between patients and controls. However, the incidence of HLA-B27 was increased in the patients complicated by ankylosing spondylitis and/or sacroiliitis in both ulcerative colitis and Crohn's disease. In contrast, none of the 29
IBD
patients with "enteropathic" peripheral arthropathy had
B27
antigen. Furthermore, ankylosing spondylitis was found more frequently in ulcerative colitis bearing HLA-B27 compared with non-
B27
patients (P less than 0-01). The same was found in Crohn's disease, although this difference was not statistically significant. In addition, 12 of 14 ulcerative colitis patients and five out of six Crohn's patients with HLA-B27 had total colitis, compared with the frequency of total colitis in non-
B27
patients (P less than 0-024 and less than 0-03 respectively). The data suggest that
B27
histocompatibility antigen could be a pathogenetic discriminator between the arthropathies in
IBD
and may be of prognostic significance with respect to extension and severity of the disease.
...
PMID:Histocompatibility antigens in inflammatory bowel disease. Their clinical significance and their association with arthropathy with special reference to HLA-B27 (W27). 100 80
The case is reported of a 50 year old man with longstanding seronegative rheumatoid arthritis who developed ulcerative colitis. The patient also had sacroiliitis and his tissue was typed as HLA-A2-
B27
several years before the bowel disease began. A possible overlap between primary
inflammatory bowel disease
, complications to the treatment of rheumatoid arthritis with drugs, and gastrointestinal rheumatoid vasculitis is discussed.
...
PMID:Ulcerative colitis complicating seronegative HLA-A2-B27 rheumatoid arthritis with sacroiliitis. 141 8
1
2
3
4
5
6
7
8
Next >>